ATE137229T1 - Umlagerungsverbindungen von taxol und deren verwendung bei der bestimmung von in vivo- aktivitäten - Google Patents

Umlagerungsverbindungen von taxol und deren verwendung bei der bestimmung von in vivo- aktivitäten

Info

Publication number
ATE137229T1
ATE137229T1 AT92301652T AT92301652T ATE137229T1 AT E137229 T1 ATE137229 T1 AT E137229T1 AT 92301652 T AT92301652 T AT 92301652T AT 92301652 T AT92301652 T AT 92301652T AT E137229 T1 ATE137229 T1 AT E137229T1
Authority
AT
Austria
Prior art keywords
taxol
ring
preferred
compounds
derivative
Prior art date
Application number
AT92301652T
Other languages
English (en)
Inventor
David G I Kingston
Gamini Samaranyake
Original Assignee
Virginia Tech Intell Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intell Prop filed Critical Virginia Tech Intell Prop
Application granted granted Critical
Publication of ATE137229T1 publication Critical patent/ATE137229T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92301652T 1991-03-18 1992-02-27 Umlagerungsverbindungen von taxol und deren verwendung bei der bestimmung von in vivo- aktivitäten ATE137229T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67043291A 1991-03-18 1991-03-18

Publications (1)

Publication Number Publication Date
ATE137229T1 true ATE137229T1 (de) 1996-05-15

Family

ID=24690379

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92301652T ATE137229T1 (de) 1991-03-18 1992-02-27 Umlagerungsverbindungen von taxol und deren verwendung bei der bestimmung von in vivo- aktivitäten

Country Status (5)

Country Link
EP (1) EP0505047B1 (de)
JP (1) JPH0684364B2 (de)
AT (1) ATE137229T1 (de)
DE (1) DE69210078D1 (de)
TW (1) TW223634B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2149150C (en) * 1992-11-27 2000-08-01 David R. Carver Injectable taxol composition with improved stability
AU5553894A (en) * 1992-11-27 1994-06-22 F.H. Faulding & Co. Limited Injectable taxol composition
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
GB9705903D0 (en) 1997-03-21 1997-05-07 Elliott Gillian D VP22 Proteins and uses thereof
AU2001288805A1 (en) 2000-09-22 2002-04-02 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
US6919370B2 (en) 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
EP3509643A1 (de) 2016-09-06 2019-07-17 Mayo Foundation for Medical Education and Research Paclitaxel-albumin-bindende wirkstoffzusammensetzungen und verfahren zur verwendung und herstellung davon

Also Published As

Publication number Publication date
DE69210078D1 (de) 1996-05-30
JPH0684364B2 (ja) 1994-10-26
EP0505047A1 (de) 1992-09-23
JPH0578342A (ja) 1993-03-30
EP0505047B1 (de) 1996-04-24
TW223634B (de) 1994-05-11

Similar Documents

Publication Publication Date Title
ATE112279T1 (de) Cc-1065 analoge.
FI875732A0 (fi) Elektrokemoluminescens- analysfoerfaranden.
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
DE69826240D1 (de) Diagnosesystem
ATE104271T1 (de) 2-(2-hydroxy-3phenoxypropylamino)ethylphenoxyacetamide, verfahren und zwischenprodukte zu deren herstellung.
ATE69221T1 (de) Verfahren zur synthese von 3-thia-4chinolonderivaten und zwischenprodukte dafuer und ihre verwendung als arzneimittel.
ATE137229T1 (de) Umlagerungsverbindungen von taxol und deren verwendung bei der bestimmung von in vivo- aktivitäten
FR2340909A1 (fr) Materiaux-supports de fermentation biologique
ATE137238T1 (de) Beta-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
IT8448702A0 (it) Impianto per la trasformazione biologica aerobica di materiali organici di rifiuto
ATE347592T1 (de) Rattenproteinkinase c und verfahren zur herstellung
ATE14225T1 (de) Benzazepin-derivate, verfahren und zwischenprodukte zu deren herstellung, deren verwendung sowie diese enthaltende arzneimittel.
DE3774590D1 (de) N-benzoyl-n'-phenylharnstoffe, ihre herstellung und verwendung bei der kontrolle von schaedlingen.
EP0097119A3 (de) Reaktivfarbstoffe, deren Herstellung und Verwendung
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
ATE100490T1 (de) Reaktor zur durchfuehrung von biologischen in vitro-prozessen, verfahren zur durchfuehrung eines biologischen in vitro-prozesses und verwendung des reaktors und des verfahrens.
DE3766898D1 (de) 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
ATE58124T1 (de) Verfahren zur herstellung von 2,2-dimethyl-3formylcyclopropancarbonsaeurepentafluorphenylmethylester, und seine verwendung bei der herstellung von pestiziden produkten.
JPS6419063A (en) Novel heterocyclic compound and use thereof
RU94027006A (ru) Способ получения 4-(гидроксиалкил)фенолов
SU486553A1 (ru) Штамм N17-255 а ибфм
IT8718703A0 (it) Processo per l'utilizzazione di materiali vegetali di scarto mediante fermentazioni aerobiche controllate precedute da pretrattamenti chimici
ATE33020T1 (de) 10,11-dihydro-5h-dibenzo(a,d>cycloheptadienderivate, ihre herstellung und verwendung.
PT86174A (de) Homogenes schaft-tiits als zwischenprodukt zur herstellung von menschlichem tiits und dessen verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties